Overview
Cytomegalovirus (CMV) hepatitis is a viral liver infection characterized by histological features including CMV inclusion bodies in hepatocytes, often observed in immunocompromised patients such as those with renal transplants or on hemodialysis 2.Diagnosis
Histological Features: Presence of CMV inclusion bodies in hepatocytes is diagnostic 2.
Immunohistochemical Staining: Detects CMV antigens in liver tissue, highlighting basophilic cytoplasmic changes indicative of viral presence 2.
Clinical Context: Common in immunocompromised individuals, particularly those with renal transplants or undergoing hemodialysis 2.Management
No Specific Doses Mentioned: General antiviral therapy targeting CMV may be considered, though specific dosing is not detailed in the provided abstracts 2.
Supportive Care: Focus on managing underlying immunosuppression and supportive measures to address liver function 2.Special Populations
Renal Transplant Patients: Higher risk due to immunosuppression; careful monitoring and prompt diagnosis crucial 2.Key Recommendations
Utilize immunohistochemical staining for definitive diagnosis of CMV hepatitis in liver biopsies 2 (Evidence: Moderate).
Closely monitor immunocompromised patients, especially those with renal transplants, for signs of CMV hepatitis 2 (Evidence: Moderate).
Implement supportive care measures tailored to the patient's overall immunosuppression status 2 (Evidence: Expert opinion).References
1 Schwartz DM. Guarded microvitreoretinal blade. Archives of ophthalmology (Chicago, Ill. : 1960) 1996. link
2 Vanstapel MJ, Desmet VJ. Cytomegalovirus hepatitis: a histological and immunohistochemical study. Applied pathology 1983. link